Thomas Koch von Net Worth & Insider Trades

Thomas Koch von Diamedica Therapeutics Inc

As of December 6, 2022

What is Thomas Koch von's Net Worth?

The current estimated net worth of Diamedica Therapeutics Inc's Thomas Koch von is estimated to be about $10.64M . Thomas Koch von owns about 2,855,847 units of Diamedica Therapeutics Inc common stock. In the last 5 months at Diamedica Therapeutics Inc, Thomas Koch von has sold an estimated value of $3.53M worth.

What is Thomas Koch von's Past Insider Trading?

Thomas Koch von's largest purchase order was 2,855,847 units , worth over $3.53M on December 6, 2022. Thomas Koch von's largest sale order was 2,855,847 units , worth over $3.53M on December 6, 2022. In total, Thomas Koch von has made about 2 transactions over 5 months of their time at Diamedica Therapeutics Inc. Thomas Koch von usually trades in December and July, with the busiest year in 2022.

Thomas Koch Von, AB TomEnterprise, AB Private TomEqt

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Thomas Koch von's' Mailing Address?

  • Mailing address is Tomenterprise Ab Box 5322 Stockholm V7 102 47 Sweden

Diamedica Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick Pauls 2020 $455,013 - $190,624 $217,716 $14,850 $878,203
Rick Pauls 2019 $420,000 - $890,736 $178,000 $14,650 $733,707
Scott Kellen 2020 $276,075 - $119,140 $79,238 $14,850 $489,303
Scott Kellen 2019 $262,500 - $336,557 $64,800 $13,950 $677,807
Harry Alcorn, Jr., Pharm.D. 2020 $291,413 - $119,140 $83,662 $14,850 $509,065
Harry Alcorn, Jr., Pharm.D. 2019 $273,750 - $421,750 $68,400 $14,400 $778,300
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm

What are Diamedica Therapeutics Inc's Past Insider Trades?

Diamedica Therapeutics Inc's most recent insider trade came on December 8, 2022 by Michael Randall Giuffre who bought 24,874 units worth $34.71K . In the last 4 years, insiders at Diamedica Therapeutics Inc have sold an estimated value of $3.53M and bought an estimated value of $5.26M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Richard Pilnik, Director,  Michael Randall Giuffre, Director,  and Scott Kellen, CFO and Secretary .

DiaMedica Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1